December 28, 2014 3:26 AM ET

Pharmaceuticals

Company Overview of Ceptaris Therapeutics, Inc.

Executive Profile

Martin Stogniew Ph.D.

Chief Development Officer, Oncoceutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 6 different industries.

See Board Relationships
59--

Background

Dr. Martin Stogniew, Ph.D. serves as the Chief Development Officer at Oncoceutics, Inc. Dr. Stogniew served as Vice President of Pharmaceutical Sciences at Ceptaris Therapeutics Inc. since July 2011. Dr. Stogniew served as Chief Technology Officer and Executive Vice President of Prestwick Pharmaceuticals, Inc. since August 30, 2007. Dr. Stogniew served as an Executive Vice President of Development at Azelon Pharmaceuticals, Inc. (Zelos Therapeutics Inc.) since May 2006. ...

Corporate Headquarters

101 Lindenwood Drive
Malvern, Pennsylvania 19355

United States

Phone: 610-975-9290
Fax: 610-975-9012

Board Members Memberships

Director

Education

PhD
University of Maryland
BS
University of Maryland

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ceptaris Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.